Youngkyong Kim, Kwan Ho Cho, Sung Ho Moon, Chang Geol Lee, Ki Chang Keum, Sang-wook Lee, Yong Chan Ahn, Dongryul Oh, Yeon-Sil Kim, Yong Kyun Won, Hong-Gyun Wu, J. Hun Hah, Young-Taek Oh
Cancer Res Treat. 2017;49(4):1097-1105. Published online February 9, 2017
Purpose
The impact of postoperative ipsilateral neck radiotherapy (INRT) versus bilateral neck radiotherapy (BNRT) on the clinical outcomes of patients with tonsillar squamous cell carcinoma was analyzed retrospectively.
Materials and Methods
Between October 2001 and June 2012, 241 patients with T1-2 and N0-N2b tonsillar carcinoma from 16 institutes underwent postoperative INRT (n=84) or BNRT (n=157) following a tonsillectomy. Seventy patientswere identified from each group by propensity score matching and compared in terms of the overall survival (OS), disease-free survival (DFS), locoregional relapse-free survival (LRRFS), and distant metastasis-free survival (DMFS) rates calculated using the Kaplan-Meier method with a log-rank test.
Results
The median follow-up was 55 months (range, 3 to 133 months). The survival outcomes in the INRT and BNRT groupswere similar: 5-year OS (92.8% vs. 94.0%, p=0.985), DFS (80.5% vs. 94.2%. p=0.085), LRRFS (88.1% vs. 97.1%, p=0.083), and DMFS (92.7% vs. 97.0%, p=0.370). Subgroup analysis revealed no contralateral neck recurrence in 61 patients with T1-2N0-2a regardless of the treatment groups. For 79 patients with N2b, contralateral neck recurrence was more common in the INRT group than in the BNRT group (7.9% vs. 0.0%), but the difference was not significant (p=0.107). The overall grade ≥ 2 toxicities were lower in the INRT group: acute (45.7% vs. 74.3%, p=0.001) and late (4.3% vs. 31.4%, p < 0.001), respectively.
Conclusion
INRT is an attractive strategy for patients with T1-2N0-2a tonsillar carcinoma compared to BNRT. For patients with N2b, there was a small risk of contralateral neck recurrence when treated with INRT, but its impact on the OS was limited with successful salvage treatment.
Citations
Citations to this article as recorded by
A multi‐institutional feasibility lead‐in trial of lymphatic mapping with SPECT–CT for evaluating contralateral disease in lateralized oropharynx cancer using 99m‐technetium sulfur colloid Leba Michael Sarkis, Christopher MKL Yao, Aaron Hendler, Ravi Mohan, Michael Au, Han Zhang, Antoine Eskander, Kevin Higgins, Danielle MacNeil, Sharon Tzelnick, David Goldstein, Ali Hosni, John R. de Almeida Head & Neck.2024; 46(12): 3038. CrossRef
Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline Danielle N. Margalit, Christopher J. Anker, Michalis Aristophanous, Musaddiq Awan, Gopal K. Bajaj, Lisa Bradfield, Joseph Califano, Jimmy J. Caudell, Christina H. Chapman, Adam S. Garden, Paul M. Harari, Amanda Helms, Alexander Lin, Ellie Maghami, Ranee M Practical Radiation Oncology.2024; 14(5): 398. CrossRef
Proton pencil beam scanning radiotherapy in the postoperative treatment of p16 positive squamous cell tonsillar cancer – evaluation of toxicity and effectivity Jiří Kubeš, Sarah Al-Hamami, Silvia Sláviková, Pavel Vítek, Alexandra Haas, Kateřina Dědečková, Barbora Ondrová, Michal Andrlik, Matěj Navrátil, Eliška Rotnáglová, Vladimír Vondráček European Archives of Oto-Rhino-Laryngology.2024; 281(10): 5447. CrossRef
Unilateral radiotherapy for tonsillar cancer with multiple ipsilateral neck lymph nodes Tae Hyun Kim, Hong-Gyun Wu, Soon-Hyun Ahn, Woo-Jin Jeong, Wonjae Cha, Keun-Yong Eom Radiation Oncology Journal.2024; 42(3): 192. CrossRef
Impact of Postoperative Neck Radiotherapy Volumes on Long‐Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma Claire M. Rooney, Shao Hui Huang, Jie Su, Scott Bratman, John Cho, John de Almeida, Michael Glogauer, David Goldstein, Ezra Hahn, Ali Hosni, Andrew Hope, Jonathan Irish, John Kim, Brian O'Sullivan, Jolie Ringash, Anna Spreafico, Jillian Tsai, John Waldron Head & Neck.2024;[Epub] CrossRef
Association of Unilateral Radiotherapy With Contralateral Lymph Node Failure Among Patients With Squamous Cell Carcinoma of the Tonsil Niema B. Razavian, Ralph B. D’Agostino, Cole R. Steber, Corbin A. Helis, Ryan T. Hughes JAMA Network Open.2023; 6(2): e2255209. CrossRef
Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma Divya Natesan, Christina K. Cramer, Taofik Oyekunle, Donna Niedzwiecki, David M. Brizel, Yvonne M. Mowery Oral Oncology.2023; 139: 106362. CrossRef
Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits Jared H Hara, Stanley I Gutiontov, Sophia Uddin, Ari J Rosenberg, Alexander T Pearson, Zhen Gooi, Elizabeth A Blair, Nishant Agrawal, Everett E Vokes, Daniel T Ginat, Daniel J Haraf, Aditya Juloori Cureus.2022;[Epub] CrossRef
Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping Ilyes Berania, Ali Hosni, Carissa M. Thomas, David Goldstein, Andrew Bayley, Ravi Mohan, Aaron Hendler, Richard M. Cooper, John R. de Almeida Journal of Otolaryngology - Head & Neck Surgery.2022;[Epub] CrossRef
Short‐term and long‐term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma Shao Hui Huang, John R. de Almeida, Erin Watson, Michael Glogauer, Wei Xu, Sareh Keshavarzi, Brian O'Sullivan, Jolie Ringash, Andrew Hope, Andrew Bayley, Scott V. Bratman, John Cho, Meredith Giuliani, John Kim, John Waldron, Anna Spreafico, David P Goldst Head & Neck.2021; 43(2): 456. CrossRef
Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary C. Jillian Tsai, Thomas J. Galloway, Danielle N. Margalit, Richard L. Bakst, Beth M. Beadle, Jonathan J. Beitler, Steven Chang, Allen Chen, Jay Cooper, Shlomo A. Koyfman, John A. Ridge, Jared Robbins, Minh Tam Truong, Sue S. Yom, Farzan Siddiqui Head & Neck.2021; 43(1): 392. CrossRef
Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma Ali Hosni, Shao Hui Huang, Wei Xu, Jie Su, Erin Watson, Michael Glogauer, Andrew Bayley, Scott V. Bratman, John Cho, Meredith Giuliani, Andrew Hope, John Kim, Brian O'Sullivan, Jolie Ringash, Anna Spreafico, David P. Goldstein, John Waldron, John R. de Al Radiotherapy and Oncology.2021; 156: 95. CrossRef
Refining Guidelines Regarding Unilateral Treatment in Patients With Well-lateralized Squamous Cell Carcinoma of the Palatine Tonsil and Multiple Positive Nodes or Extranodal Extension Robert J. Amdur, Paul M. Harari, Peter T. Dziegielewski, William M. Mendenhall Practical Radiation Oncology.2021; 11(3): e247. CrossRef
Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck Sandra Nuyts, Heleen Bollen, Avrahram Eisbruch, June Corry, Primoz Strojan, Antti A. Mäkitie, Johannes A. Langendijk, William M. Mendenhall, Robert Smee, Remco DeBree, Anne W. M. Lee, Alessandra Rinaldo, Alfio Ferlito Head & Neck.2021; 43(9): 2807. CrossRef
The treatment of tonsillar squamous cell carcinoma at Hue Central Hospital Phuong Nam Tran Journal of Clinical Medicine- Hue Central Hospital.2021;[Epub] CrossRef
Efficacy of Postoperative Unilateral Neck Irradiation in Patients with Buccal Mucosa Squamous Carcinoma with Extranodal Extension: A Propensity Score Analysis Chia-Hsin Lin, Chien-Yu Lin, Kang-Hsing Fan, Sheng-Ping Hung, Yung-Chih Chou, Chia-Jen Liu, Wen-Chi Chou, Yen-Chao Chen, Shiang-Fu Huang, Chung-Jan Kang, Kai-Ping Chang, Hung-Ming Wang, Ann-Joy Cheng, Joseph Tung-Chieh Chang Cancers.2021; 13(23): 5997. CrossRef
Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: A retrospective study Axel Sahovaler, John J. W. Lee, Wei Xu, Susie Su, Ali Hosni, Andrew Bayley, David P. Goldstein, John R. de Almeida Journal of Otolaryngology - Head & Neck Surgery.2021;[Epub] CrossRef
Lymphatic mapping with SPECT‐CT for evaluation of contralateral drainage in lateralized oropharyngeal cancers using an awake injection technique Carissa M. Thomas, Mohemmed N. Khan, Ravi Mohan, Aaron Hendler, Ali Hosni, Douglas B. Chepeha, David P. Goldstein, Richard M Cooper, John R. de Almeida Head & Neck.2020; 42(3): 385. CrossRef
Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck Hidenori Kimura, Satoshi Hamauchi, Sadayuki Kawai, Yusuke Onozawa, Hirofumi Yasui, Aiko Yamashita, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuro Onitsuka, Tomoya Yokota International Journal of Clinical Oncology.2020; 25(2): 258. CrossRef
Désescalade thérapeutique dans les cancers de l’oropharynx induit par les HPV : mise au point C. Lahmamssi, J.-B. Guy, N. Benchekroun, Z. Bouchbika, N. Taoufik, H. Jouhadi, S. Sahraoui, A. Benider, M. Ben Mrad, O. Jmour, A. Bousarsar, M.L. Lan, Q. Lei, M. Benna, D. Moslemi, A. Vallard, N. Magné Cancer/Radiothérapie.2020; 24(3): 258. CrossRef
The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors Sonja Stieb, Ismael Perez-Martinez, Abdallah S.R. Mohamed, Stockton Rock, Nimit Bajaj, Tanaya S. Deshpande, Mohamed Zaid, Adam S. Garden, Ryan P. Goepfert, Richard Cardoso, Renata Ferrarotto, Jay P. Reddy, Jack Phan, William H. Morrison, David I. Rosentha Clinical and Translational Radiation Oncology.2020; 24: 71. CrossRef
Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? Yonca Onbasi, Sebastian Lettmaier, Markus Hecht, Sabine Semrau, Heinrich Iro, Marco Kesting, Rainer Fietkau, Marlen Haderlein Strahlentherapie und Onkologie.2019; 195(6): 482. CrossRef
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update Julian Biau, Michel Lapeyre, Idriss Troussier, Wilfried Budach, Jordi Giralt, Cai Grau, Joanna Kazmierska, Johannes A. Langendijk, Mahmut Ozsahin, Brian O'Sullivan, Jean Bourhis, Vincent Grégoire Radiotherapy and Oncology.2019; 134: 1. CrossRef
Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer Jared Gershowitz, Hann-Hsiang Chao, Abigail Doucette, John N Lukens, Samuel Swisher-McClure, Gregory S Weinstein, Bert W O’Malley Jr, Ara A Chalian, Christopher H Rassekh, Jason G Newman, Roger B Cohen, Joshua M Bauml, Charu Aggarwal, Alexander Lin The British Journal of Radiology.2019;[Epub] CrossRef
Seongyeol Park, Soo Jeong Nam, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, J. Hun Hah, Tack-Kyun Kwon, Dong-Wan Kim, Myung-Whun Sung, Dae Seog Heo, Yung-Jue Bang
Cancer Res Treat. 2016;48(2):518-526. Published online July 14, 2015
Purpose The purpose of this study was to evaluate potential prognostic factors in patients with adenoid cystic carcinoma (ACC). Materials and Methods A total of 68 patients who underwent curative surgery and had available tissue were enrolled in this study. Their medical records and pathologic slides were reviewed and immunohistochemistry for basic fibroblast growth factor, fibroblast growth factor receptor (FGFR) 2, FGFR3, c-kit, Myb proto-oncogene protein, platelet-derived growth factor receptor beta, vascular endothelial growth factor (VEGF), and Ki-67 was performed. Univariate and multivariate analysis was performed for determination of disease-free survival (DFS) and overall survival (OS).
Results In univariate analyses, primary site of nasal cavity and paranasal sinus (p=0.022) and Ki-67 expression of more than 7% (p=0.001) were statistically significant factors for poor DFS. Regarding OS, perineural invasion (p=0.032), high expression of VEGF (p=0.033), and high expression of Ki-67 (p=0.007) were poor prognostic factors. In multivariate analyses, primary site of nasal cavity and paranasal sinus (p=0.028) and high expression of Ki-67 (p=0.004) were independent risk factors for poor DFS, and high expression of VEGF (p=0.011) and Ki-67 (p=0.011) showed independent association with poor OS. Conclusion High expression of VEGF and Ki-67 were independent poor prognostic factors for OS in ACC.
Citations
Citations to this article as recorded by
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands Vasudha Mishra, Alka Singh, Michael Korzinkin, Xiangying Cheng, Claudia Wing, Viktoria Sarkisova, Ashwin L. Koppayi, Alexandra Pogorelskaya, Oksana Glushchenko, Manu Sundaresan, Venkat Thodima, Jack Carter, Koichi Ito, Peggy Scherle, Anna Trzcinska, Ivan Journal of Experimental & Clinical Cancer Research.2025;[Epub] CrossRef
Sinonasal adenoid cystic carcinoma: preoperative apparent diffusion coefficient histogram analysis in prediction of prognosis and Ki-67 proliferation status Jingfeng Cheng, Quan Liu, Yuzhe Wang, Yang Zhan, Yin Wang, Dandan Shen, Yue Geng, Linying Guo, Zuohua Tang Japanese Journal of Radiology.2024;[Epub] CrossRef
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials Youjin Kim, Bhumsuk Keam, Eun Joo Kang, Jin-Soo Kim, Hye Ryun Kim, Keun-Wook Lee, Jung Hye Kwon, Kyoung Eun Lee, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Moon Young Choi, Ki Hyeong Lee, Sung-Bae Kim, Myung-Ju Ahn Cancer Research and Treatment.2024; 56(4): 1068. CrossRef
Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma Parisa Bayat, Nazanin Mahdavi, Shima Younespour, Neda Kardouni Khoozestani Clinical and Experimental Dental Research.2023; 9(1): 112. CrossRef
Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy Quan-Quan Lin, Jin-Long Sun, Feng Wang, Hai-Zhong Zhang, Ge Zhou, Qing Xi Holistic Integrative Oncology.2023;[Epub] CrossRef
Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma Alessandro Marchioni, Roberto Tonelli, Anna Valeria Samarelli, Gaia Francesca Cappiello, Alessandro Andreani, Luca Tabbì, Francesco Livrieri, Annamaria Bosi, Ottavia Nori, Francesco Mattioli, Giulia Bruzzi, Daniele Marchioni, Enrico Clini International Journal of Molecular Sciences.2023; 24(14): 11370. CrossRef
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma Glenn J. Hanna, Myung-Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong, Alan L. Ho, Sung-Bae Kim, Francis Worden, Tak Yun, Xianzhang Meng, Jan M. Van Tornout, Maureen G. Conlan, Hyunseok Kang Clinical Cancer Research.2023; 29(22): 4555. CrossRef
A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma Lauren E. Miller, Vivienne Au, Tara E. Mokhtari, Deborah Goss, Daniel L. Faden, Mark A. Varvares Cancers.2022; 14(4): 992. CrossRef
Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma Luana Guimaraes de Sousa, Felippe Lazar Neto, Jessica Lin, Renata Ferrarotto Current Oncology Reports.2022; 24(5): 621. CrossRef
Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments Luana Guimaraes de Sousa, Katarina Jovanovic, Renata Ferrarotto Current Treatment Options in Oncology.2022; 23(8): 1135. CrossRef
The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now? Robbert Cleymaet, Tijl Vermassen, Renaat Coopman, Hubert Vermeersch, Stijn De Keukeleire, Sylvie Rottey International Journal of Molecular Sciences.2022; 23(23): 14891. CrossRef
Approaches to the Management of Metastatic Adenoid Cystic Carcinoma Rex H. Lee, Katherine C. Wai, Jason W. Chan, Patrick K. Ha, Hyunseok Kang Cancers.2022; 14(22): 5698. CrossRef
Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy James Nightingale, Benedict Lum, Rahul Ladwa, Fiona Simpson, Benedict Panizza Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1875(2): 188523. CrossRef
Apatinib in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a single-arm, phase II prospective study Guopei Zhu, Lin Zhang, Shengjin Dou, Rongrong Li, Jiang Li, Lulu Ye, Wen Jiang, Minjun Dong, Min Ruan, Wenjun Yang, Chenping Zhang Therapeutic Advances in Medical Oncology.2021;[Epub] CrossRef
Impact of tumor site on the prognosis of salivary gland neoplasms: A systematic review and meta-analysis Erison Santana dos Santos, Carla Isabelly Rodrigues-Fernandes, Paul M. Speight, Syed Ali Khurram, Ibrahim Alsanie, Ana Gabriela Costa Normando, Ana Carolina Prado-Ribeiro, Thaís Bianca Brandão, Luiz Paulo Kowalski, Eliete Neves Silva Guerra, Marcio Ajudar Critical Reviews in Oncology/Hematology.2021; 162: 103352. CrossRef
Molecular Markers that Matter in Salivary Malignancy Katherine C. Wai, Hyunseok Kang, Patrick K. Ha Otolaryngologic Clinics of North America.2021; 54(3): 613. CrossRef
Asymptomatic Palatal Mass C. V. Divyambika, K. Satish Srinivas, S. Sathasiva Subramanian, S. Elengkumaran, N. Malathi Indian Journal of Dental Research.2021; 32(1): 120. CrossRef
Anlotinib is effective in patients with advanced oral cancer? Chen Chu, Wei Shang, Yan Sun, Xiaochun Zhang Medical Hypotheses.2020; 137: 109578. CrossRef
Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression R. Cordesmeyer, R. Laskawi, H. Schliephake, P. Kauffmann, J. Beck, K. Bornemann-Kolatzki, E. Schütz, P. Ströbel, S. Kueffer, A. Fichtner, F. Bremmer Oral Oncology.2020; 103: 104615. CrossRef
Knockdown Rab11‐FIP2 inhibits migration and invasion of nasopharyngeal carcinoma via suppressing Rho GTPase signaling Guofei Feng, Liting Qin, Zhipeng Liao, Xiling Xiao, Bo Li, Wanmeng Cui, Libin Liang, Yingxi Mo, Guangwu Huang, Ping Li, Xiaoying Zhou, Zhe Zhang, Xue Xiao Journal of Cellular Biochemistry.2020; 121(2): 1072. CrossRef
Major and minor salivary gland tumours Gemma Gatta, Marco Guzzo, Laura D. Locati, Mark McGurk, Franz Josef Prott Critical Reviews in Oncology/Hematology.2020; 152: 102959. CrossRef
The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis Xiangqi Liu, Dongru Chen, Xiaomei Lao, Yujie Liang Head & Neck.2019; 41(5): 1517. CrossRef
New approaches in salivary gland carcinoma Caroline Even, Neus Baste, Marion Classe Current Opinion in Oncology.2019; 31(3): 169. CrossRef
Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland Junya Ono, Yasuo Okada Odontology.2018; 106(3): 238. CrossRef
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma A.L. Ho, L. Dunn, E.J. Sherman, M.G. Fury, S.S. Baxi, R. Chandramohan, S. Dogan, L.G.T. Morris, G.D. Cullen, S. Haque, C.S. Sima, A. Ni, C.R. Antonescu, N. Katabi, D.G. Pfister Annals of Oncology.2016; 27(10): 1902. CrossRef
The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis Jun Ju, Yun Li, Juan Chai, Chao Ma, Qianwei Ni, Zhiyuan Shen, Jianhua Wei, Moyi Sun Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2016; 122(6): 691. CrossRef
Purpose This study evaluates the long-term results of definitive radiotherapy (RT) for early glottic cancer. Clinical and treatment factors related to local control and patterns of failure are analyzed. Materials and Methods We retrospectively reviewed 222 patients with T1-2N0 squamous cell carcinoma of the glottic larynx treated with definitive RT from 1981 to 2010. None of the patients received elective nodal RT or combined chemotherapy. The median total RT dose was 66 Gy. The daily fraction size was < 2.5 Gy in 69% and 2.5 Gy in 31% of patients. The RT field extended from the hyoid bone to the cricoid cartilage.
Results The median age was 60 years, and 155 patients (70%) had T1 disease. The 5-year rates of local recurrence-free survival (LRFS) and ultimate LRFS with voice preservation were 87.8% and 90.3%, respectively. T2 (hazard ratio [HR], 2.30; 95% confidence interval [CI], 1.08 to 4.94) and anterior commissural involvement (HR, 3.37; 95% CI, 1.62 to 7.02) were significant prognostic factors for LRFS. In 34 patients with local recurrence, tumors recurred in the ipsilateral vocal cord in 28 patients. There were no contralateral vocal cord recurrences. Most acute complications included grade 1-2 dysphagia and/or hoarseness. There was no grade 3 or greater chronic toxicity.
Conclusion Definitive RT achieved a high cure rate, voice preservation, and tolerable toxicity in early glottic cancer. T2 stage and anterior commissural involvement were prognostic factors for local control. Further optimization of the RT method is needed to reduce the risk of ipsilateral tumor recurrence.
Citations
Citations to this article as recorded by
Superior Regional Control and Laryngeal Function Preservation With Radiotherapy Versus Partial Laryngectomy: A Propensity Score‐Matched Analysis of 562 Early Glottic Cancer Patients Shaoqiu Zhang, Ruichen Li, Yang Zhao, Liting Zhu, Ming Guo, Xiaoshen Wang, Yi Zhu Head & Neck.2025;[Epub] CrossRef
Dosimetric comparison between carotid-sparing IMRT and 3DCRT in early glottic cancer patients treated with definitive radiation therapy Harkirat Kaur, Niketa Thakur, Ramita Sharma, Meena Sudan, Neeraj Jain, Supreet Kaur, Priyanka Lehal Journal of Cancer Research and Therapeutics.2024; 20(1): 327. CrossRef
Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI Seok-Joo Chun, Jaeman Son, Seonghee Kang, Chang Heon Choi, Jung-in Kim, Young-Il Kim, Joo Ho Lee, Jin Ho Kim, Hong-Gyun Wu Strahlentherapie und Onkologie.2024; 200(5): 418. CrossRef
Oncological and Functional Outcomes for Horizontal Glottectomy: A Systematic Review Matteo Fermi, Alfredo Lo Manto, Cecilia Lotto, Giulia Cianci, Francesco Mattioli, Daniele Marchioni, Livio Presutti, Ignacio Javier Fernandez Journal of Clinical Medicine.2023; 12(6): 2261. CrossRef
Prospective Observational Comparative Study of Response and Toxicities in Early Glottic Cancer Using Telecobalt Versus 3D-CRT Sanchayan Mandal, Tamohan Chaudhuri, Dhrubajyoti Mukhopadhyay Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S2): 1725. CrossRef
Neck Dissection in Salvage Surgery for Larynx Cancer: National Cancer Database Review Tirth R. Patel, Jaijeet Toor, Bobby A. Tajudeen, Mihir Bhayani, Samer Al-Khudari Annals of Otology, Rhinology & Laryngology.2022; 131(4): 379. CrossRef
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu Radiation Oncology Journal.2022; 40(2): 120. CrossRef
Early‐stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy Alexandra N. de Leo, Roi Dagan, Christopher G. Morris, Adam L. Holtzman, Kathryn E. Hitchcock, Curtis M. Bryant, Robert J. Amdur, William M. Mendenhall Head & Neck.2022; 44(11): 2513. CrossRef
Long-term impact of smoking cessation on new glottic cancer events in patients with early glottic cancer Min-Su Kim, Hong-Gyun Wu, Myung-Whun Sung, Tack-Kyun Kwon Acta Otorhinolaryngologica Italica.2022; 42(6): 525. CrossRef
Laser Microsurgery Versus Radiotherapy Versus Open Partial Laryngectomy for T2 Laryngeal Carcinoma: A Systematic Review of Oncological Outcomes Flaminia Campo, Jacopo Zocchi, Massimo Ralli, Daniele De Seta, Francesca Yoshie Russo, Diletta Angeletti, Antonio Minni, Antonio Greco, Raul Pellini, Marco de Vincentiis Ear, Nose & Throat Journal.2021; 100(1_suppl): 51S. CrossRef
Occult Lymph Node Metastasis in Early‐Stage Glottic Cancer in the National Cancer Database Tirth R. Patel, Michael Eggerstedt, Jaijeet Toor, Bobby A. Tajudeen, Inna Husain, Kerstin Stenson, Samer Al‐Khudari The Laryngoscope.2021;[Epub] CrossRef
Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer N. Patrik Brodin, Rafi Kabarriti, Clyde B. Schechter, Mark Pankuch, Vinai Gondi, Shalom Kalnicki, Madhur K. Garg, Wolfgang A. Tomé Radiation Oncology.2021;[Epub] CrossRef
Early glottic cancer recurrence: A critical review on its current management Luca Giovanni Locatello, Chiara Bruno, Oreste Gallo Critical Reviews in Oncology/Hematology.2021; 160: 103298. CrossRef
TLM Outcomes in Elderly Patients with Glottic Pre-Malignancy and Early Malignancy; A 12-Year Retrospective Study Heidi Jones, Elizabeth Ross, Jemy Jose Annals of Otology, Rhinology & Laryngology.2021; 130(12): 1392. CrossRef
Prognostic value of the maximum standardized uptake value for the locoregional control in early glottic cancer Donghyun Kim, Yongkan Ki, Jihyeon Joo, Hosang Jeon, Dahl Park, Jiho Nam, Wontaek Kim Radiation Oncology Journal.2021; 39(4): 297. CrossRef
Outcomes of carotid‐sparing IMRT for T1 glottic cancer: Comparison with conventional radiation Abdallah S.R. Mohamed, Blaine D. Smith, Joshua B. Smith, Parag Sevak, Jessica S. Malek, Aasheesh Kanwar, Theodora Browne, G. Brandon Gunn, Adam S. Garden, Steven J. Frank, William H. Morrison, Jack Phan, Mark Zafereo, Heath Skinner, Stephen Y. Lai, Kather The Laryngoscope.2020; 130(1): 146. CrossRef
Helical Radiotherapy in Early Laryngeal Cancers Could Lead to Excess Local Recurrence: Lessons From a Phase II Prospective Study S. Chatterjee, I. Mallick, S. Chakraborty, S. Prasath, M. Arunsingh, R.B. Achari, B. Arun, C. Nallathambi, A. Pattatheyil, S. Sen Clinical Oncology.2020; 32(2): e67. CrossRef
MACC1 expression is an indicator of recurrence in early-stage glottic cancer Takuma Makino, Yorihisa Orita, Yuka Gion, Tomoyasu Tachibana, Soshi Takao, Hidenori Marunaka, Kentaro Miki, Naoki Akisada, Yusuke Akagi, Tadashi Yoshino, Kazunori Nishizaki, Yasuharu Sato Japanese Journal of Clinical Oncology.2020; 50(4): 392. CrossRef
Is tailored management better than salvage in laryngeal squamous cell carcinomas Bhargaw Ilapakruty, Vishal U. S. Rao Head & Neck.2020; 42(2): 357. CrossRef
Chemoradiotherapy for high-risk stage II laryngeal cancer Satoshi Hamauchi, Tomoya Yokota, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuro Onitsuka, Hirofumi Yasui International Journal of Clinical Oncology.2020; 25(9): 1596. CrossRef
Transoral laser microsurgery for glottic cancer in the elderly: Efficacy and safety Juan P. Rodrigo, Fabian García‐Velasco, Petra Ambrosch, Vincent Vander Poorten, Carlos Suárez, Andrés Coca‐Pelaz, Primoz Strojan, Kate Hutcheson, Benedikt J. Folz, Manuel Bernal‐Sprekelsen, Alessandra Rinaldo, Carl E. Silver, Alfio Ferlito Head & Neck.2019; 41(6): 1816. CrossRef
Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer Byung-Hee Kang, Tosol Yu, Jin Ho Kim, Jong Min Park, Jung-In Kim, Eun-Jae Chung, Seong Keun Kwon, Ji-Hoon Kim, Hong-Gyun Wu International Journal of Radiation Oncology*Biology*Physics.2019; 105(1): 104. CrossRef
Prognostic factors in patients with T1 glottic cancer treated with radiotherapy A. Mucha-Małecka, A. Chrostowska, K. Urbanek, K. Małecki Strahlentherapie und Onkologie.2019; 195(9): 792. CrossRef
Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution Jeong Won Lee, Jeong Eun Lee, Junhee Park, Jin Ho Sohn, Dongbin Ahn Radiation Oncology Journal.2019; 37(2): 82. CrossRef
Outcome of Early-Stage Glottic Laryngeal Carcinoma Patients Treated with Radical Radiotherapy Using Different Techniques Oguz Cetinayak, Ersoy Dogan, Ahmet Kuru, Nesrin Akturk, Barbaros Aydin, Cenk Umay, Ilhami Er, Fadime Akman Journal of Oncology.2019; 2019: 1. CrossRef
Involvement of the Anterior Commissure in Early Glottic Cancer (Tis-T2): A Review of the Literature Martine Hendriksma, Elisabeth V. Sjögren Cancers.2019; 11(9): 1234. CrossRef
Patterns of failure for early-stage glottic carcinoma Fatma Sert, Isa Kaya, Kerem Ozturk, Mustafa Esassolak Journal of Cancer Research and Therapeutics.2019; 15(3): 576. CrossRef
Oncologic outcomes of KTP laser surgery versus radiation for T1 glottic carcinoma Jamal Ahmed, Ahmed Sherif Gabr Ibrahim, Laura M. Freedman, David E. Rosow The Laryngoscope.2018; 128(5): 1052. CrossRef
Study design and early result of a phase I study of SABR for early‐stage glottic cancer Tosol Yu, Chan Woo Wee, Noorie Choi, Hong‐Gyun Wu, Hyun‐Cheol Kang, Jong Min Park, Jung‐In Kim, Jin Ho Kim, Tack‐Kyun Kwon, Eun‐Jae Chung The Laryngoscope.2018; 128(11): 2560. CrossRef
Clinicopathological Characteristics and Survival Rate of Patients with Laryngeal Squamous Cell Carcinoma: A Retrospective Study during 2011–2017 in Yazd, Iran Shokouh T Zahir, Koorosh Rahmani, Meisam Mehri, Mohammad Shafiee, Seyed M Reza Mortazavizadeh International Journal of Phonosurgery & Laryngology.2018; 8(2): 65. CrossRef
Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results Faya Liang, Song Fan, Ping Han, Qian Cai, Peiliang Lin, Renhui Chen, Shitong Yu, Xiaoming Huang Surgical Endoscopy.2017; 31(2): 894. CrossRef
Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes L. Warner, K. Lee, J.J. Homer Clinical Otolaryngology.2017; 42(3): 629. CrossRef
Impact of Close and Positive Margins in Transoral Laser Microsurgery for Tis–T2 Glottic Cancer Ivana Fiz, Francesco Mazzola, Francesco Fiz, Filippo Marchi, Marta Filauro, Alberto Paderno, Giampiero Parrinello, Cesare Piazza, Giorgio Peretti Frontiers in Oncology.2017;[Epub] CrossRef
Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case SEUNG-GU YEO Molecular and Clinical Oncology.2016; 4(3): 429. CrossRef
Tae Ryool Koo, Hong-Gyun Wu, J. Hun Hah, Myung-Whun Sung, Kwang-Hyun Kim, Bhumsuk Keam, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, Dae-Seog Heo, Charn Il Park
Cancer Res Treat. 2012;44(4):227-234. Published online December 31, 2012
PURPOSE The purpose of this study is to analyze treatment outcome of radiotherapy (RT) in patients with stage III-IV tonsil cancer managed by surgery followed by postoperative RT (SRT) and definitive chemoradiotherapy (CRT), and to thereby evaluate the most feasible treatment modality. MATERIALS AND METHODS Of 124 patients, 67 underwent CRT, and 57 underwent SRT. We compared survival and complication rates in both groups. RESULTS The median follow-up time was 57 months (range, 19 to 255 months) for surviving patients. At five years, locoregional progression-free survival (LRPFS) and overall survival (OS) were 88% and 80%, respectively. No significant difference in LRPFS (p=0.491) and OS (p=0.177) was observed between CRT and SRT. In multivariate analysis, old age and higher T stage showed a significant association with poor LRPFS, PFS, and OS; higher N stage showed an association with poor PFS and a trend of poor LRPFS, while no association with OS was observed; treatment modality (CRT and SRT) showed no association with LRFPS, PFS, and OS.
Grade 3 or higher mucositis was observed in 12 patients (21%) in the SRT group, and 25 patients (37%) in the CRT group. CONCLUSION Definitive CRT and SRT have similar treatment outcomes for patients with stage III-IV tonsil cancer.
Although acute complication rate appears to be higher in the CRT group, it should be noted that not all data on complications were included in this retrospective study. To determine the most feasible treatment modality, not only mucositis and xerostomia, but also emotional aspect and quality of life, should be considered.
Citations
Citations to this article as recorded by
Risk of lymph node metastasis in T1 tonsil squamous cell carcinomas patients according to age stratification at diagnosis Yujiao Li, Chaosu Hu American Journal of Otolaryngology.2024; 45(6): 104452. CrossRef
Detection of the high-risk factors for synchronous bone metastasis in tonsillar squamous cell carcinoma Yujiao Li, Chaosu Hu European Archives of Oto-Rhino-Laryngology.2023; 280(10): 4619. CrossRef
The treatment of tonsillar squamous cell carcinoma at Hue Central Hospital Phuong Nam Tran Journal of Clinical Medicine- Hue Central Hospital.2021;[Epub] CrossRef
Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study Sanghyuk Song, Hong-Gyun Wu, Chang Geol Lee, Ki Chang Keum, Mi Sun Kim, Yong Chan Ahn, Dongryul Oh, Hyo Jung Park, Sang-Wook Lee, Geumju Park, Sung Ho Moon, Kwan Ho Cho, Yeon-Sil Kim, Yongkyun Won, Young-Taek Oh, Won-Taek Kim, Jae-Uk Jeong BMC Cancer.2017;[Epub] CrossRef
Long-term results of ipsilateral radiotherapy for tonsil cancer Tae Ryool Koo, Hong-Gyun Wu Radiation Oncology Journal.2013; 31(2): 66. CrossRef
Impact of Postoperative Chemoradiotherapy and Chemoradiotherapy Alone for Esophageal Cancer in North-West Iran Seyed Kazem Mirinezhad, Mohammad Hossein Somi, Masoud Shirmohamadi, Farshad Seyednejad, Amir Ghasemi Jangjoo, Morteza Ghojazadeh, Mohammad Mohammadzadeh, Ali Reza Naseri, Behnam Nasiri Asian Pacific Journal of Cancer Prevention.2013; 14(6): 3921. CrossRef